Objective: Ruptured aortic aneurysms (rAAs) are associated with high mortality. The purpose of this study was to describe the trends of deaths due to rAA in the United States.
Ruptured aortic aneurysms (rAAs) are associated with high mortality risk, approaching 90%. 1 The prevalence of aortic aneurysms dramatically increases after the age of 50 years and is associated with traditional cardiovascular risk factors. 2, 3 Aortic aneurysm rupture may be prevented by early recognition and elective repair. During the past decades, the incidence of rAA is believed to have decreased because of primordial prevention (decreased prevalence of risk factors), primary prevention (population screening programs and elective repair), and improvement in surgical care for ruptured aneurysms. 4, 5 A recent study has shown a decrease in ruptured abdominal aortic aneurysm (rAAA)-related hospitalizations from 21 to 16 per 100,000 persons in England and from 10 to 7 per 100,000 persons in the United States. 6 Despite that, aortic aneurysms and dissection were ranked as the 15th leading cause of death for people aged 65 years and older in the United States. 6 Globally, the estimated incidence of deaths due aortic aneurysms decreased by 12.7% from 3.3 per 100,000 persons (1990) to 2.9 per 100,000 persons (2010). 7 Fatal rAA, however, appears to have significant geographic variation. For example, a study of death certificates from São Paolo, Brazil (1985 Brazil ( -2009 ), has shown a significant increase in mortality related to rAA from 4 to 7 per 100,000 persons. 8 In another study from the United Kingdom, the mortality rates for all abdominal aortic aneurysms (AAAs) increased between 1979 and 1999 from 1.3 to 2.5 per 100,000 in women and from 8.0 to 11.5 per 100,000 in men. 9 More recently, another study 
METHODS
We conducted a retrospective review of the Multiple Causes of Death records, maintained by the U.S. National Center for Health Statistics (NCHS), using the Centers for Disease Control and Prevention (CDC) Wide-ranging OnLine Data for Epidemiologic Research (WONDER) platform. The detailed mortality database consists of mortality data on all deaths of U.S. residents (inpatients and outpatients) based on death certificates and includes underlying causes of death, demographic data, and geographic data. This registry serves as the primary source to track mortality rates and causes of death in the United States. Institutional Review Board approval was waived as only cumulative data are used. We selected patients aged 15 years or older who had aortic aneurysm in the Multiple Cause of Death records between 1999 and 2016. During this period, all causes of death were registered within the NCHS using the International Classification of Diseases, Tenth Revision (ICD-10). Aortic aneurysms were defined by ICD-10 codes as follows: thoracic aortic aneurysm, I71.1 (thoracic aortic aneurysm, ruptured) or I71.2 (thoracic aortic aneurysm, without mention of rupture); AAAs, I71.3 (AAA, ruptured) or I71.4 (AAA, without mention of rupture); thoracoabdominal aortic aneurysms, I71.5 (thoracoabdominal aortic aneurysm, ruptured) or I71.6 (thoracoabdominal aortic aneurysm, without mention of rupture); and aortic aneurysms of unspecified site, I71.8 (aortic aneurysm of unspecified site, ruptured) or I71.9 (aortic aneurysm of unspecified site, without mention of rupture). We also performed similar analyses using the same ICD-10 codes mentioned in the Multiple Cause of Death records. Among these patients, contributing causes of death were defined by the following ICD-10 codes: I10-I15, hypertension; I20-I25, ischemic heart disease; I21-I22, acute myocardial infarction; I35.0, aortic stenosis; I35.1, aortic insufficiency; I35.2, aortic stenosis with insufficiency; I46, cardiac arrest; I60-69, cerebrovascular diseases; I63, cerebral infarction; I74, arterial thrombosis; E10-E14,(diabetes; and C00-C97, cancer.
We explored the association between national prevalence of tobacco use (available from the CDC at https://www.cdc. gov/tobacco/data_statistics/tables/trends/cig_smoking/ index.htm) and trends in mortality. We additionally explored the association between state-level mortality rates and the state-level average temperature and difference in temperature between winter months and summer months (available from the National Centers for Environmental Information at https://www.ncdc.noaa.gov/). We also investigated the association between geographic rAA mortality with state-level tobacco use (available from the CDC at https://www.cdc.gov/statesystem/cigaretteuseadult.html).
Statistical analyses. Crude mortality rates are presented per 1 million persons, and age-adjusted mortality rates were standardized to the 2000 U.S. Census data. Trends in mortality were tested using Spearman correlation test (mortality vs year), and multivariable associations were analyzed using linear regression models. The c 2 test was used to compare rates. All tests were performed using Statistical Package for the Social Sciences (SPSS version 20; IBM, Armonk, NY). P < .05 was considered statistically significant.
RESULTS
A total of 104,458 deaths due to rAA occurred during the study period (13.2% ruptured thoracic aortic aneurysms [rTAAs], 64.8% rAAAs, 1.5% ruptured Recommendation: This study documents a significant decline in death due to ruptured aortic aneurysm during the past 17 years.
thoracoabdominal aortic aneurysms, and 20.5% rAAs of unspecified site). The overall age-adjusted incidence was 23.3 per 1 million persons. The site-specific ageadjusted mortality was as follows: rTAA, 3.1 per 1 million persons; rAAA, 15.1 per 1 million persons; ruptured thoracoabdominal aortic aneurysm, 0.4 per 1 million persons; and rAA of unspecified site, 4.8 per 1 million persons (Fig 1) . Mean age at death was 77.0 6 11.3 years; 62% were male, and 92% were white.
The incidence of thoracic aortic aneurysm was higher among white women compared with white men (3.5 vs 3.3 per 1 million, P < .001), but it was the same in black men vs black women (2.6 vs 2.3 per 1 million; P < .001; Fig 2) . Mortality due to rAAA showed a more consistent male predominance across races: white men vs women, 24.3 vs 11.9 per 1 million (P < .001); black men vs women, 7.1 vs 4.6 per 1 million (P < .001; Fig 2) . Between 1999 and 2016, the overall age-adjusted incidence of rAA decreased from 40 to 12.8 per million (rTAA from 5.5 to 1.8 and rAAA from 26.3 to 7.9 per 1 million; P < .001 for all comparisons; Fig 3) . These trends were consistent across age groups, sexes, and races (Supplementary Table I , online only). The male to female age-adjusted mortality ratio decreased from 3.3 (1999) to 2.6 (2016) in rAAA (P < .001 for trend) but remained unchanged in rTAA, 1.5 (1999) to 1.3 (2016; P ¼ .12 for trend). The rate of rAA mortality increased with age: 0.6 (<45 years) to 302.4 (85þ years) per 1 million persons (Fig 4) ; rTAA, 0.3 (<45 years) to 38.3 (85þ years) per 1 million; rAAA, 0 (<45 years) to 199.2 (85þ years) per 1 million persons. Overall, 57% of rAAA deaths occurred among men $65 years, whereas 34% occurred in women and 9% occurred in men younger than 65 years. Contributing causes of death in patients who died of rAA are shown in Supplementary Table II (online  only) .
The number of rAA deaths varied according to season of death (averaged during 17 years; P ¼ .011 for rAA, P ¼ .004 for rTAA, P ¼ .03 for rAAA; Fig 5) Supplementary Fig, online only) . There was no correlation between state-level tobacco use burden and rAA (r ¼ 0.27; P ¼ .06), rTAA (r ¼ 0.06; P ¼ .69), or rAAA (r ¼ 0.24; P ¼ .09).
In using rAA in any of the multiple causes of deaths, there were a total of 113,637 deaths. Overall ageadjusted incidence (per 1 million) was 25.3 for rAA, 3.5 for rTAA, and 16.3 for rAAA. The age-adjusted rates of rAA decreased from 42.2 (1999) to 14.9 (2016); rTAA, from 6.0 (1999) to 2.2 (2016); and rAAA, from 27.9 (1999) to 9.1 (2016), per 1 million (P < .001 for all trends). Age, sex, race, and geographic variations were similar to rAA as underlying cause of death.
DISCUSSION
This study showed a downward trend in overall mortality due to rAAs in the United States, mainly because of a decrease in the incidence of fatal rAAA. The incidence rates showed significant differences between site, age, sex, races, and geographic location.
The reasons for the decrease in mortality due to rAAA remain speculative but are likely multifactorial. Risk factor modification, population screening, improvement in regional centralization, adequate emergency preparedness, and improvement in surgical training and surgical and postsurgical care have all contributed to decreased incidence. 20, 21 Given that our data were obtained from death certificates with limited information, we were unable to examine the factors associated with the decrease in rAA. We show, however, that the downward trend in rAA mortality remained significant despite adjustment for prevalence of tobacco use. These trends are concordant with recent studies from other parts of the world, such as the United Kingdom, The Netherlands, and Australia. 9,22,23 A study of death certificates in São increase in age-adjusted mortality due to rAA and aortic dissection, which was hypothesized to be due to increased life expectancy and an increase in agerelated diseases. This suggests that the trends observed in our study may not be consistent across countries. Our data suggest that there is a seasonal variation in mortality due to rAA, with a peak during the winter months and a nadir during the summer months. These findings have been demonstrated in previous smaller reports. [24] [25] [26] The reasons for the seasonal variations are unknown but are thought to be due to variations in temperature and blood pressure. Blood pressure measurements are higher in cold weather than they are in warm weather. 27, 28 In one study of elderly communitydwelling persons, the proportion with blood pressure >160/90 mm Hg was fourfold higher in winter than in summer. 29 The mean temperature-related variation in blood pressure reported in studies is small, and it is unclear whether it explains the seasonal variation in rAAs. In addition, thermoregulatory adjustment to the ambient temperature results in thrombocytosis, increasing blood viscosity. 25, 30 These physiologic changes could enhance the shear stress against the aortic wall, resulting in higher incidence of acute aortic syndromes. In fact, our study suggests that there is a relationship between regional temperature differences between seasons and incident rAA, but this requires further investigation. These findings were also supported by the geographic variation in death rate due to both rAAA and rTAA, which was significantly higher in the northern part compared with the southern part of the United States, possibly reflecting ambient temperature effect. We show that a significant number of rAAA deaths occur in patients not currently included in the AAA screening guidelines. The U.S. Preventive Services Task Force recommends one-time screening for AAA with ultrasound only for men aged 65 to 75 years who have ever smoked or have first-degree relatives with an AAA. 31 Because the incidence of fatal rAAA is higher in men, the cost-effectiveness of screening women for AAA has not yet been proven. In this study, 43% of rAAA deaths (34% in women and 9% in younger men) occurred in patients not included in the AAA screening criteria. This is higher than findings of a retrospective study from Finland between 2002 and 2013, which showed that 18% of rAAAs occurred in patients younger than the current screening age. 32 Whereas the prevalence of AAA is four times higher in men than in women, 33 the mortality rate due to AAA observed in our study was only twice as high in men as in women. This perhaps reflects a faster growth rate, lower threshold for rupture, higher likelihood of fatal rupture, and poorer surgical outcomes in women compared with men. 34, 35 Our data also reflect the focus on AAA screening and prevention of rupture in men, as evidenced by the decrease in the male to female rAAA mortality ratio over time. Further studies are required to identify the efficacy and costeffectiveness of population-based screening for AAA in women.
A number of limitations in this study must be acknowledged. Ascertainment of causes of death is often difficult, especially in out-of-hospital deaths that do not undergo autopsy, and thus rAA mortality rate may be underestimated. Moreover, we excluded patients who died of thoracic aortic aneurysms, AAAs, and thoracoabdominal aortic aneurysms without mention of rupture on death certificates, which may lead to underestimation of rAA mortality. We also lack granular clinical data, such as anatomic data, aneurysm size, comorbidities, and risk factors, that may have contributed to the changes in mortality. However, our study has major strengths, including the use of recently updated nationally representative NCHS data through 2016. This data set is used for reporting of major causes of death by major societies in the United States and serves as a reference for epidemiologic reporting of death in the U.S. population.
CONCLUSIONS
The incidence of fatal rAA, rTAA, and rAAA drastically decreased in the United States between 1999 and 2016, a trend that was consistent across age groups, sexes, and races. A significant percentage of fatal rAAAs occurred in patients who are not eligible for the current screening program. 
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